Scholars Central

Conference abstractPublished 17 Sep 2012

CDH5 is specifically activated in glioblastoma stem like cells and contributes to vasculogenic mimicry induced by hypoxia

Authors: Xiang Zhang

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

A portion of glioblastoma stem like cells (GSCs) expressing CDH5 (VE-Cadherin or CD144), a specific marker for endothelial cells (ECs), can trans-differentiate into ECs and form blood vessels in glioblastoma (GBM). However, the implication of CDH5 expression in gliomas, and how its expression is regulated in GSCs remain to be clarified. Here, we demonstrated that CDH5 is overexpressed in gliomas, correlated with tumor grades, and is an unfavorable predictor for GBM patients. Immuno histochemistry analysis revealed that CDH5 expression was observed in tumor cells in addition to ECs in GBM tissues. Interestingly, CDH5 is specifically activated in GSCs but not in non-GSCs or NSCs, indicated by quantitative real-time PCR and western blot. Bioinformatics analysis showed that CDH5 may interact directly with angiogenesis-associated genes and hypoxia inducible factor 2Ã?± (HIF2Ã?±). CDH5 expression was significantly upregulated in GSCs, but not in non-GSCs or normal NSCs, under 1% O 2 condition. Knockdown of either HIF1Ã?± or HIF2Ã?± by shRNA significantly decreased CDH5 level in GSCs by about 90%, and abolished the induction of CDH5 under hypoxia. Furthermore, ChIP analysis revealed that both HIF1Ã?± and HIF2Ã?± can bind to the promoter of CDH5. In vitro angiogenesis assay demonstrated that CDH5 contributes to vasculogenic mimicry of GSCs, especially under hypoxia. Therefore, the specific expression of CDH5 in GSCs may contribute to the GSC-derived neovasculogenesis in glioblastoma, especially under hypoxia conditions. Our results revealed promising mechanisms controlling trans-differentiation of GSCs into ECs regulated by hypoxia, and provided new insights in the mechanisms of hypoxia induced angiogenesis in GBMs.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Translational Medicine.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalTranslational Medicine
  • SubjectGeneral & Internal Medicine
  • BylineArticles whose byline prints “Xiang Zhang”